Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ampicillin + azithromycin vs ampicillin + cefazolin in premature rupture of membranes
IRCT20241107063630N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Dec 2024
- Modality
- Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in Rupture of amniotic membranes (PROM) comparing Ampicillin + azithromycin with Ampicillin + cefazolin (2 arms). Started Dec 2024; status: completed.
02
Drugs
ampicillinazithromycincefazolin
03
Conditions
Rupture of amniotic membranes (PROM)
Beyond the preview
Go deeper on IRCT20241107063630N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241107063630N1.